Boardroom Alpha
Boardroom Alpha
RYAN · Current Report (Form 8-K) · Filed February 12, 2026

Ryan Specialty Holdings Inc — Current Report (Form 8-K)

Form
8-K
Filed
February 12, 2026
Period
Feb 10, 2026
Ticker
RYAN
Accession
0001628280-26-007479
Boardroom Alpha · Filing insights

Ryan Specialty sets 2026 annual meeting for April 28 (virtual) with proposal and nomination deadlines.

About Ryan Specialty Holdings Inc
Market cap
$8.5B
1Y TSR
−52.7%
3Y TSR
−8.6%
Board grade
C-
Sector
Financial Services
CEO
Timothy William Turner
Last annual meeting: Apr 28, 2026 · View full Ryan Specialty Holdings Inc profile →
ryan-20260210
UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
WASHINGTON, D.C. 20549
____________________
FORM 8-K
____________________
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported): February 10, 2026
____________________
RYAN SPECIALTY HOLDINGS, INC.
(Exact name of Registrant as Specified in Its Charter)
____________________
Delaware
001-40645
86-2526344
(State or Other Jurisdiction
of Incorporation)
(Commission File Number)
(IRS Employer
Identification No.)
155 North Wacker Drive, Suite 4000
Chicago, Illinois
60606
(Address of Principal Executive Offices)
(Zip Code)
Registrant’s Telephone Number, Including Area Code: 312 784-6001
(Former Name or Former Address, if Changed Since Last Report)
____________________
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the
registrant under any of the following provisions:
o
Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)
o
Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)
o
Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))
o
Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))
Securities registered pursuant to Section 12(b) of the Act:
Title of each class
Trading
Symbol(s)
Name of each exchange on which registered
Class A Common Stock, $0.001 par value
RYAN
The New York Stock Exchange
Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act
of 1933 (§ 230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§ 240.12b-2 of this chapter).
Emerging growth company o
If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition
period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the
Exchange Act. o
Item 5.08 Shareholder Director Nominations.
To the extent applicable, the information in Item 8.01 of this Current Report on Form 8-K is incorporated by reference into
this Item 5.08.
Item 8.01 Other Events.
The Board of Directors of Ryan Specialty Holdings, Inc. (the “Company”) has set the date of April 28, 2026 for the annual
meeting of stockholders (the “2026 Annual Meeting”) to be held virtually by means of remote communication. The record
date for the purpose of determining stockholders entitled to notice of, and vote at, the 2026 Annual Meeting has been set as
the close of business on March 2, 2026.
Deadline for Rule 14a-8 Stockholder Proposals
Under the Securities and Exchange Commission’s rules, the Company has set the deadline for submission of proposals to
be included in the proxy materials for the 2026 Annual Meeting pursuant to Rule 14a-8 as February 22, 2026, which the
Company has determined to be a reasonable time before it expects to begin to print and send its proxy materials.
Accordingly, in order for a stockholder proposal to be considered for inclusion in the Company’s proxy materials for the
2026 Annual Meeting pursuant to Rule 14a-8, such proposal must be received by the Company at 155 North Wacker Dr.,
Suite 4000, Chicago, IL 60606, Attention: Corporate Secretary, on or before February 22, 2026, and comply with the
procedures and requirements set forth in Rule 14a-8 under the Securities Exchange Act of 1934.
Advance Notice Deadline for Director Nominations and Other Stockholder Proposals
In accordance with the Company’s Amended and Restated Bylaws, for director nominations or stockholder proposals to be
brought before the 2026 Annual Meeting, other than Rule 14a-8 proposals described above, written notice must be received
by the Company at 155 North Wacker Dr., Suite 4000, Chicago, IL 60606, Attention: Corporate Secretary, no later than the
close of business on February 20, 2026, and comply with the requirements of the Company's Amended and Restated
Bylaws and Rule 14a-19 under the Securities Exchange Act of 1934.
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed
on its behalf by the undersigned hereunto duly authorized.
RYAN SPECIALTY HOLDINGS, INC. (Registrant)
Date:
February 12, 2026
By:
/s/ Mark S. Katz
Mark S. Katz
Executive Vice President, General Counsel and Corporate
Secretary
From this filing to the file

Every SEC filing, parsed structured.

Boardroom Alpha indexes every 8-K, 10-K, 10-Q, and proxy back to 2000 — vote tabulations, comp tables, red flags, insider transactions, all queryable the day they hit EDGAR.

Independent — issuer-pays-free, ideology-free, U.S.-owned.

More filings

Other filings from Ryan Specialty Holdings Inc (RYAN)

Reference

Frequently asked questions

When did Ryan Specialty Holdings Inc file this 8-K?
Ryan Specialty Holdings Inc (RYAN) filed this Current Report (Form 8-K) with the SEC on February 12, 2026. The accession number assigned by EDGAR is 0001628280-26-007479.
What does an 8-K disclose?
Form 8-K is the SEC's current-report form, used to disclose material events between periodic reports (10-K / 10-Q). Triggers include CEO/CFO departures, acquisitions, bankruptcies, earnings releases, auditor changes, changes in fiscal year, and amendments to corporate governance. Each 8-K is keyed to one or more Item numbers (1.01 through 9.01).
What is the key takeaway from this filing?
Ryan Specialty sets 2026 annual meeting for April 28 (virtual) with proposal and nomination deadlines. This is Boardroom Alpha's one-line summary of the current report; see the full filing text above for the formal disclosure.
What Item codes does an 8-K cover?
An 8-K's Item codes (1.01 through 9.01) specify what kind of event is being disclosed — e.g. Item 1.01 for entering a material agreement, Item 5.02 for departure/election of directors and executive officers, Item 8.01 for other events. The Item codes for this 8-K appear in the filing text above.
Where can I find Ryan Specialty Holdings Inc's prior current reports on EDGAR?
The SEC EDGAR browser lists every 8-K Ryan Specialty Holdings Inc has filed under CIK 1849253, sortable by date. Use the "View on SEC EDGAR" link in the page header, or browse directly via https://www.sec.gov/cgi-bin/browse-edgar.
Disclaimer

The opinions and information contained herein have been obtained or derived from sources believed to be reliable, but Boardroom Alpha cannot guarantee its accuracy and completeness, and that of the opinions based thereon.

This report contains opinions and is provided for informational purposes only – it does not constitute investment, legal or tax advice. You should not rely solely upon the research herein for purposes of transacting securities or other investments, and you are encouraged to conduct your own research and due diligence, and to seek the advice of a qualified securities professional before you make any investment.

None of the information contained in this report constitutes, or is intended to constitute a recommendation by Boardroom Alpha of any particular security or trading strategy or a determination by Boardroom Alpha that any security or trading strategy is suitable for any specific person. To the extent any of the information contained herein may be deemed to be investment advice, such information is impersonal and not tailored to the investment needs of any specific person.

No representation or warranty, expressed or implied, is made on behalf of Boardroom Alpha as to the accuracy or completeness of the information contained herein. Boardroom Alpha does not accept any liability for any direct, indirect or consequential loss or damage suffered by any person as a result of relying on all or any part of this research and any liability is expressly disclaimed.

Full disclaimer